Scribd Logo
Upload

Welcome to Scribd!

  • Searl Glaxo Hinoon Abot Iblhl Macter Otsu Agp Sanofi

    Uploaded by

    Laraib Mohib
    3 views3 pages
    The document contains financial metrics such as EPS, EPS growth, PER, DPS, DY, PBV, ROE, P/S, and P/E forward for various companies. It also lists potential upside triggers such as new product announcements and downside risks such as currency depreciation for some companies. Target prices are provided for some companies in June 2019.

    Original Description:

    Ratios of pharma sector in Pak

    Original Title

    Pharma Pak ratios

    Copyright

    © © All Rights Reserved

    Available Formats

    XLSX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document contains financial metrics such as EPS, EPS growth, PER, DPS, DY, PBV, ROE, P/S, and P/E forward for various companies. It also lists potential upside triggers such as new product announcements and downside risks such as currency depreciation for some companies. Target prices are provided for some companies in June 2019.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    3 views3 pages

    Searl Glaxo Hinoon Abot Iblhl Macter Otsu Agp Sanofi

    Uploaded by

    Laraib Mohib
    The document contains financial metrics such as EPS, EPS growth, PER, DPS, DY, PBV, ROE, P/S, and P/E forward for various companies. It also lists potential upside triggers such as new product announcements and downside risks such as currency depreciation for some companies. Target prices are provided for some companies in June 2019.

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 3

    SEARL GLAXO HINOON Abot IBLHL Macter OTSU AGP* SANOFI

    EPS (Rs.) 15.44 8.27 25.40 35.61 2.34 5.84 2.67 4.53 67.11
    EPS Growth (%) -4.73% 22.63% -16.86% 95.27% 56.92% 41.11% 327.60% -2.72% -52.39%
    PER (x) Trailing 17.48 17.38 12.20 19.04 21.62 22.26 68.30 18.98 12.83
    DPS (Rs.) 5.00 4.00 10.00 40.00 1.00 3.25 1.20 2.50 4.50
    DY (%) 1.85% 2.78% 3.23% 5.90% 1.98% 2.50% 0.66% 2.90% 0.52%
    PBV (x) 3.91 3.26 3.30 5.28 2.25 4.25 10.69 3.94 1.90
    ROE (%) 20.50% 18.75% 25.60% 27.75% 14.50% 19.10% 15.62% 20.78% 14.79%
    P/S (x) 4.36 1.39 0.89 2.29 1.97 1271.77 1.22 4.48 0.65
    P/E forward 17.55 17.63 12.45 24.46 26.78 38.92 158.80 19.15 10.18
    Target Price June
    2019 280.00 N/A N/A N/A N/A N/A N/A 113.00 N/A

    Highest
    Insulin business Cheapest impact of
    Strong
    announcement multiple- price hike on
    consumer
    Triggers up side expected; high wise; Sehat hardship
    products
    impact of price Card cases; Sehat
    segment
    hike Programme Card
    Programme

    Downside Sector Further PKR depreciation, Peshawer High Court verdict on Price hike Reversal
    Triggers
    FEROZSON
    3.29
    -60.88%
    57.99
    2.00
    1.05%
    0.04
    2.06%
    1.25
    22.78

    N/A

    You might also like